| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q3 2024 | 75 | 254,551 | PLTR, DFAC, AVLC, DFIC | 13F-HR | 11/1/2024 | 000182561124000004 |
| Q2 2024 | 72 | 211,177 | PLTR, DFAC, AVLC, DFIC | 13F-HR | 7/26/2024 | 000182561124000003 |
| Q1 2024 | 71 | 195,306 | PLTR, DFAC, AVLC, DFIC | 13F-HR | 5/7/2024 | 000182561124000002 |
| Q4 2023 | 54 | 134,616 | PLTR, DFAC, DFAT, DFIC | 13F-HR | 1/17/2024 | 000182561124000001 |
| Q3 2023 | 52 | 113,859 | PLTR, DFAC, DFAT, GLD | 13F-HR | 10/31/2023 | 000182561123000004 |
| Q2 2023 | 42 | 93,867 | PLTR, DFAC, DFAT, TSLA | 13F-HR | 7/20/2023 | 000182561123000003 |
| Q1 2023 | 39 | 70,924 | DFAC, PLTR, DFAT, SCHH | 13F-HR | 5/8/2023 | 000182561123000002 |
| Q4 2022 | 37 | 63,794 | DFAC, PLTR, VTV, DFAT | 13F-HR | 2/1/2023 | 000182561123000001 |
| Q3 2022 | 25 | 53,825 | PLTR, VGSH, DFAC, TSLA | 13F-HR | 10/31/2022 | 000182561122000005 |
| Q2 2022 | 23 | 56,992 | PLTR, VGSH, DFAC, SCHH | 13F-HR | 8/8/2022 | 000182561122000004 |
| Q1 2022 | 33 | 98,436 | PLTR, TSLA, U, VGSH | 13F-HR | 4/28/2022 | 000182561122000003 |
| Q4 2021 | 29 | 107,886 | PLTR, AFRM, BROOKLYN IMMUNOTHERAPEUTICS, U | 13F-HR | 1/27/2022 | 000182561122000002 |
| Q3 2021 | 172 | 140,150 | PLTR, AFRM, U, ABNB | RESTATEMENT | 11/5/2021 | 000182561121000007 |
| Q2 2021 | 200 | 140,642 | PLTR, U, BROOKLYN IMMUNOTHERAPEUTICS, AFRM | 13F-HR | 8/4/2021 | 000182561121000005 |
| Q1 2021 | 110 | 96,082 | PLTR, U, LPRO, TSLA | 13F-HR | 5/6/2021 | 000182561121000003 |
| Q4 2020 | 196 | 65,780 | LPRO, TSLA, SCHB, BRK-B | 13F-HR | 2/5/2021 | 000182561121000002 |